Sage's depression drug succeeds in mid-stage study

Sage's depression drug succeeds in mid-stage study

REUTERS: Sage Therapeutics Inc said on Thursday its drug to treat patients with moderate to severe depression met the main goal in a mid-stage study.

The 89-patient study testing the drug, SAGE-217, showed statistically significant reduction of depression symptoms, compared to a placebo.

(Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by Shounak Dasgupta)

Source: Reuters

Bookmark